ArticleNature communications2026
Applying asymmetric-waveform alternating current in nickel-catalyzed asymmetric reductive cross-coupling.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alternating-Polarity Electrolysis Enables Efficient Enantioselective Semipinacol Rearrangement Using Sodium Chloride.Journal of the American Chemical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Asymmetric waveform alternating current electrocatalysis (asym. AC-eChem) is introduced as a powerful and versatile platform that overcomes key limitations in electrochemical reductive cross-coupling chemistry. By precisely tuning electrode materials, forward / reverse current magnitude, duty ratio, and frequencies, asym. AC-eChem effectively addresses challenges associated with traditional direct current (DC) methods, such as cathodic over-reduction and anodic metal salt deposition. Through nickel-catalyzed asymmetric reductive cross-coupling, this method enables the dialkylation of alkynes with two non-activated alkyl halides, which are traditionally challenging substrates due to their difficult reduction properties and similar reduction potentials, while also providing precise control over chemo-, regio-, E/Z-, and enantio-selectivities. It efficiently produces axially chiral compounds, including deuterated methyl and ethyl derivatives with pharmaceutical relevance. Furthermore, the resulting products can be readily transformed into phosphine ligands, which exhibit exceptional performance in palladium-catalyzed asymmetric allylation reactions. The scalability and industrial viability of this strategy are demonstrated through a custom-designed flow electrochemical system. Overall, this protocol establishes asymmetric waveform AC electrocatalysis as a transformative method for advancing electrochemical reductive cross-coupling.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.